- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
PCMT1 as a prognostic marker in breast cancer ; day:5 ; month:9 ; year:2024 ; pages:1-11
Clinical and translational oncology ; (5.9.2024), 1-11
- Urheber
-
Rogaczewski, Patryk
Janiak, Michał
Borowczak, Jędrzej
Szylberg, Łukasz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-024-03695-y
- URN
-
urn:nbn:de:101:1-2411212203578.194745867842
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rogaczewski, Patryk
- Janiak, Michał
- Borowczak, Jędrzej
- Szylberg, Łukasz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells